Clínica Universidad de Navarra is a tertiary care hospital in Northern Span. The Liver Unit has an extensive experience in therapeutic innovation in hepatocellular carcinoma (HCC). In collaboration with the Department of Immunology and Immunotherapy has led national and international clinical trials that support the use of immune checkpoint inhibitors for the treatment of this tumor.
Bruno Sangro MD heads the Liver Unit at Clínica Universidad de Navarra and is Professor of Medicine at the School of Medicine. He has been principal investigator for several clinical trials on immunotherapy of HCC. Pablo Sarobe PhD has a long-standing experience in immunology of liver disease including liver cancer. Mercedes Iñarrairaegui MD is Consultant at the Liver Unit and has a strong focus on translational and clinical research in liver cancer. The group will collaborate in patient recruitment, clinical analysis and immune validation in animal models.